NovoCure (NVCR)

• Market cap: $1.43B
• 1 day: -0.08%
• 5 days: -6.84%
• 1 month: -0.85%
• 3 months: 10.72%
• 6 months: -29.38%
• Year to date: -57.29%
• 1 year: -15.61%
• 5 years: -88.58%
• 10 years: -46.24%
• Sector: Healthcare
• Industry: Medical Devices

About: NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

Employees: 1,488